Atıf İçin Kopyala
Ozluk Y., Firat P., Yegen G., Hocaoglu J., Tas S., Yilmazbayhan D.
CYTOPATHOLOGY, cilt.28, sa.1, ss.35-45, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
28
Sayı:
1
-
Basım Tarihi:
2017
-
Doi Numarası:
10.1111/cyt.12357
-
Dergi Adı:
CYTOPATHOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.35-45
-
Anahtar Kelimeler:
lung cancer, epidermal growth factor receptor, molecular, cytology, TTF-1, GROWTH-FACTOR RECEPTOR, THYROID TRANSCRIPTION FACTOR-1, CYTOLOGY SPECIMENS, GENE-MUTATIONS, PROGNOSTIC-FACTOR, CANCER, SAMPLES, CLASSIFICATION, CYTOPATHOLOGY, GEFITINIB
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Objective: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown benefits regarding progression-free and overall survival in patients whose tumours show EGFR mutations. Most patients' lung cancer is metastatic when detected. Small tissue samples and cytological materials are widely used in diagnosis. The aim of the present study was to compare the EGFR mutation analysis results between cytology, small biopsies and resections.